Reprogramming TREM1+ Myeloid Cells to Overcome Immunotherapy Resistance in Solid Tumors

Time: 10:00 am
day: Day Two


• Exemplifying how depletion of different myeloid cell subsets can affect different features of the tumor microenvironment, modulate effector cell activity, and promote tumorigenesis

• Discussing the tolerability of different targets

• Drawing up next steps in clinical development for myeloid-targeting therapies